These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2889827)

  • 21. Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain.
    Klimek V; Zak-Knapik J; Mackowiak M
    J Psychiatry Neurosci; 1994 Jan; 19(1):63-7. PubMed ID: 8148368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increases in guanine nucleotide binding to striatal G proteins is associated with dopamine receptor supersensitivity.
    Butkerait P; Wang HY; Friedman E
    J Pharmacol Exp Ther; 1994 Oct; 271(1):422-8. PubMed ID: 7965743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of long-term treatment with amine-depleting drugs or chlorpromazine on alpha-adrenoreceptors and 5-HT2 receptors in the brain of the rat.
    Hong M; Roots EJ; Jenner P; Marsden CD
    Neuropharmacology; 1988 May; 27(5):519-27. PubMed ID: 2899303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
    Burger LY; Martin-Iverson MT
    Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine receptor turnover rates in rat striatum are age-dependent.
    Leff SE; Gariano R; Creese I
    Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3910-4. PubMed ID: 6587399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of aging on the electrophysiologic responses to verapamil in isolated perfused rat hearts.
    Schmidlin O; Garcia J; Schwartz JB
    J Pharmacol Exp Ther; 1991 Jul; 258(1):130-5. PubMed ID: 2072290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors.
    Buckholtz NS; Zhou DF; Freedman DX
    Life Sci; 1988; 42(24):2439-45. PubMed ID: 3374263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of the receptor turnover using an irreversible inactivating method. Theoretical assumptions, limitations and practical realization.
    Nowak G
    Pol J Pharmacol Pharm; 1990; 42(5):433-40. PubMed ID: 1983029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influences of reserpine and imipramine on the 5-HT2 receptor binding site and its coupled second messenger in rat cerebral cortex.
    Lee MJ; Wei JW
    Chin J Physiol; 2013 Aug; 56(4):199-208. PubMed ID: 23806035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional variability in changes in 5-HT2A receptor mRNA levels in rat brain following irreversible inactivation with EEDQ.
    Raghupathi RK; Artymyshyn R; McGonigle P
    Brain Res Mol Brain Res; 1996 Jul; 39(1-2):198-206. PubMed ID: 8804728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of serotonin2, but not of beta-adrenergic receptors during chronic treatment with amitriptyline is independent of stimulation of serotonin2 and beta-adrenergic receptors.
    Scott JA; Crews FT
    Neuropharmacology; 1986 Dec; 25(12):1301-6. PubMed ID: 3031528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding profile of trazodone and dapiprazole to some brain receptors.
    Valeri P; Palmery M; Silvestrini B
    Drugs Exp Clin Res; 1988; 14(1):53-8. PubMed ID: 2839325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of metaphit on phencyclidine and serotonin2 receptors.
    Nabeshima T; Tohyama K; Noda A; Maeda Y; Hiramatsu M; Harrer SM; Kameyama T; Furukawa H; Jacobson AE; Rice KC
    Neurosci Lett; 1989 Jul; 102(2-3):303-8. PubMed ID: 2554211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic electroconvulsive seizures increase the expression of serotonin2 receptor mRNA in rat frontal cortex.
    Butler MO; Morinobu S; Duman RS
    J Neurochem; 1993 Oct; 61(4):1270-6. PubMed ID: 8376984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Region-specific serotonin1A receptor turnover following irreversible blockade with EEDQ.
    Keck BJ; Lakoski JM
    Neuroreport; 1996 Nov; 7(15-17):2717-21. PubMed ID: 8981454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nefazodone: preclinical pharmacology of a new antidepressant.
    Eison AS; Eison MS; Torrente JR; Wright RN; Yocca FD
    Psychopharmacol Bull; 1990; 26(3):311-5. PubMed ID: 2274630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-related assessment of central 5-HT1A receptors following irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Keck J; Lakoski JM
    Brain Res; 1996 Jul; 728(1):130-4. PubMed ID: 8864308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aging: changes in distribution of diazepam and metabolites in the rat.
    Rahman A; Komiskey HL; Hayton WL; Weisenburger WP
    Drug Metab Dispos; 1986; 14(3):299-302. PubMed ID: 2872028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoradiographic analysis of age-dependent changes in serotonin 5-HT2 receptors of the human brain postmortem.
    Gross-Isseroff R; Salama D; Israeli M; Biegon A
    Brain Res; 1990 Jun; 519(1-2):223-7. PubMed ID: 2397409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neural adaptation in response to chronic imipramine and electroconvulsive shock: evidence for separate mechanisms.
    Paul IA; Duncan GE; Mueller RA; Hong JS; Breese GR
    Eur J Pharmacol; 1991 Nov; 205(2):135-43. PubMed ID: 1687466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.